StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly short-term borrowings and current maturities of long-term debt ($M) ($M)

Annual figures from Eli Lilly's filings and investor materials

Latest, FY2025
1,635
Period ended Dec 31, 2025
Change on a year earlier
-68.0%
5,117 in FY2024
History
14 years
Since FY2012
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShort-term borrowings and current maturities of long-term debt ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,635-68.0%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 20245,117-25.9%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 20236,905+360.0%Form 10-K (filed 2024-02-21) ↗
FY2022Dec 31, 20221,501-2.4%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 20211,538+17,581.6%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 20208.70-99.4%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 20191,499+36.0%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 20181,102-70.3%Form 10-Q (filed 2019-05-02) ↗
FY2017Dec 31, 20173,707+91.3%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 20161,937+31,660.7%Form 10-K (filed 2017-02-21) ↗
FY2015Dec 31, 20156.10-99.8%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20142,689+165.5%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 20131,013+8,409.2%Form 10-Q (filed 2014-04-28) ↗
FY2012Dec 31, 201211.9–Form 10-Q (filed 2013-10-30) ↗

Cite this data

StockData. (2026). Eli Lilly Short-term borrowings and current maturities of long-term debt ($M) ($M), annual FY2012–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_cur_debt

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.